A Study of CAR-T Cells Targeting Autoimmune Diseases

StatusWithdrawn
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Withdrawn before enrolling Sponsor's reason: No participants. Show 4 more changesShow less
    • Enrollment target: estimated 12 to confirmed 0
    • Primary completion date changed from estimate of Apr 20, 2028 to Apr 30, 2026
    • Eligibility criteria expanded, about 9 words
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.
Trial Details
NCT Number NCT06661811
Lead Sponsor Beijing Boren Hospital
Conditions
(from sponsor)		 Autoimmune Diseases
Related terms Autoimmune Diseases
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov